Ivonescimab Antibody
Ivonescimab (AK112) is a bispecific antibody targeting both PD-1 and VEGF, designed for cancer immunotherapy and anti-angiogenic therapy in NSCLC. It is utilized in preclinical research to investigate its mechanisms and efficacy in both in vitro cellular assays and in vivo tumor models.
Product Specifications
Product Name Alternative
AK 112, AK112, SMT112, SMT-112
Target
PD-1/PD-L1, VEGFR
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Cell Biology, Immunology & Inflammation, Signal Transduction
Concentration
9.55 mg/mL
Purity
>95.0% (May vary between batches)
Molecular Weight
201.12 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
YP-W28685-01 48 Tests
Mouse C1q And Tumor Necrosis Factor Related Protein 1 (C1QTNF1) ELISA Kit
Sign In for Pricing
View Details YP-W28685-02 96 Tests
Mouse C1q And Tumor Necrosis Factor Related Protein 1 (C1QTNF1) ELISA Kit
Sign In for Pricing
View Details bs-2908R-HRP-01 20 µL
MAPKAP Kinase 2 Polyclonal Antibody, HRP Conjugated
Sign In for Pricing
View Details bs-2908R-HRP-02 100 µL
MAPKAP Kinase 2 Polyclonal Antibody, HRP Conjugated
Sign In for Pricing
View Details 